Comprehensive Cardiovascular Pharmacology

In this comprehensive two-part series, nurse practitioners and clinical nurse specialists are updated on the latest information about cardiovascular pharmacotherapeutic agents as well as their side effects.

Included in this talk is information on:

Cardiovascvular Pharmacology Part 1

  • Hyperlipidemia, Lipoproteins, and the Pathogenesis of Plaque Rupture
  • Newest Lipid Lowering Guidelines
  • Treating Hyperlipidemia: HMG-CoA Reductase Inhibitors, Bile Acid Sequestrants, Fibrates, Cholesterol Absorption Inhibitor, Niacin, Other Agents for Dyslipidemia
  • Myocardial Infarction
  • Managing Hypertension: JNC-8 Guidelines (vs. JNC-7)
  • Pharmacologic Hypertension Agents: Diuretics, ACE-inhibitors, Angiotensin II Receptor Blockers, Calcium Channel Blockers, Beta-Blocking Agents, Peripheral Alpha1-Antagonists, Central Alpha2-Agonists, Arterial Vasodilators, Direct Renin Inhibitors, and Adrenergic Antagonists
  • Isolated Systolic Hypertension
  • Special Patient Populations
  • Hypertensive Crises vs. Emergencies

Cardiovascvular Pharmacology Part 2

  • Heart Failure: Key Concepts, Compensatory Mechanisms, and the Neurohormonal Model
  • Treating Heart Failure: Diuretics, ACE-Inhibitors, Angiotensin II-Receptor Blockers, Beta-blocking Agents, Aldosterone Antagonists, Vasodilators (HYD/Nitrate), Cardiac Glycosides, Digoxin, Dihydropyridine CCB, Inotropic Agents, Dobutamine, Milrinone, Intravenous Vasodilators, Nitroglycerin, Nitroprusside, Nesiritide, Mechanical Circulatory Support
  • Treating Anginal Syndromes: Nitrates, Beta-blockers, CCBs, and Ranolazine, Adjunct Pharmacologic Therapy
  • Drugs for Dysrhythmias
  • Drugs for Coagulation Problems: Anticoagulants, Antiplatelets, and Thrombolytic Agents
  • Treating Peripheral Arterial Disease
  • Hemostatic Agents